You have 9 free searches left this month | for more free features.

ABBV-951

Showing 1 - 25 of 121

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Subcutaneous Infusion of ABBV-951 to Assess Change in Disease

Not yet recruiting
  • Parkinson's Disease (PD)
    • (no location specified)
    Jun 15, 2023

    ABBV-951 Subcutaneous Infusion to Assess Change in Disease

    Not yet recruiting
    • Parkinson's Disease (PD)
      • (no location specified)
      Oct 25, 2023

      Parkinson's Disease Trial in United States (ABBV-951)

      Recruiting
      • Parkinson's Disease
      • ABBV-951
      • Aurora, Colorado
      • +9 more
      Jun 7, 2022

      Parkinson's Disease (PD) Trial in Australia, United States (ABBV-951)

      Enrolling by invitation
      • Parkinson's Disease (PD)
      • ABBV-951
      • Birmingham, Alabama
      • +52 more
      Oct 17, 2022

      Parkinson's Disease (PD) Trial in Worldwide (ABBV-951)

      Completed
      • Parkinson's Disease (PD)
      • ABBV-951
      • Birmingham, Alabama
      • +64 more
      Sep 23, 2022

      Parkinson's Disease (PD) Trial in Worldwide (ABBV-951)

      Enrolling by invitation
      • Parkinson's Disease (PD)
      • ABBV-951
      • Birmingham, Alabama
      • +49 more
      Jan 18, 2022

      Parkinson's Disease (PD) Trial in United States (ABBV-951)

      Completed
      • Parkinson's Disease (PD)
      • ABBV-951
      • Glendale, California
      • +6 more
      Nov 13, 2019

      Parkinson's Disease (PD) Trial in United States (ABBV-951)

      Completed
      • Parkinson's Disease (PD)
      • ABBV-951
      • Sun City, Arizona
      • +11 more
      Mar 12, 2019

      Progressive Supranuclear Palsy Trial in Worldwide (Placebo, ABBV-8E12)

      Terminated
      • Progressive Supranuclear Palsy
      • Birmingham, Alabama
      • +65 more
      Feb 1, 2021

      Healthy Volunteers Trial in Glendale (TAK-951 Placebo, TAK-951)

      Completed
      • Healthy Volunteers
      • Glendale, California
        California Clinical Trials Medical Group
      Oct 11, 2022

      Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

      Recruiting
      • Small Cell Lung Cancer
      • Birmingham, Alabama
      • +32 more
      Oct 5, 2022

      Healthy Volunteers Trial (ABBV-903)

      Not yet recruiting
      • Healthy Volunteers
      • (no location specified)
      Oct 5, 2023

      Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-927, ABBV-181)

      Active, not recruiting
      • Advanced Solid Tumors Cancer
      • Los Angeles, California
      • +21 more
      Jan 20, 2023

      Acute Myeloid Leukemia Trial (ABBV-787)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Sep 29, 2023

      Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

      Recruiting
      • Advanced Solid Tumors Cancer
      • New Haven, Connecticut
      • +29 more
      Dec 5, 2022

      Healthy Volunteers Trial in Anaheim, Las Vegas (ABBV-552)

      Recruiting
      • Healthy Volunteers
      • Anaheim, California
      • +1 more
      Jan 13, 2023

      B-cell Lymphoma Trial in Israel, Puerto Rico, Turkey (ABBV-623, ABBV-992)

      Terminated
      • B-cell Lymphoma
      • Ramat Gan, Tel-Aviv, Israel
      • +4 more
      Feb 2, 2023

      Upper Limb Spasticity Trial (ABBV-950, BOTOX, Placebo for ABBV-950)

      Not yet recruiting
      • Upper Limb Spasticity
      • ABBV-950
      • +2 more
      • (no location specified)
      Jul 14, 2023

      ABBV-154 Trial in Grayslake, Las Vegas (ABBV-154 Dose Formulation A, ABBV-154 Dose Formulation B)

      Active, not recruiting
      • ABBV-154
      • ABBV-154 Dose Formulation A
      • ABBV-154 Dose Formulation B
      • Grayslake, Illinois
      • +1 more
      Dec 19, 2022

      Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)

      Not yet recruiting
      • Unresectable Metastatic Colorectal Cancer
      • (no location specified)
      Oct 25, 2023

      Dry Eye Syndrome Trial in Azusa (ABBV-444)

      Recruiting
      • Dry Eye Syndrome
      • Azusa, California
        Canyon City Eyecare /ID# 253652
      May 24, 2023

      Healthy Trial (ABBV-CLS-7262)

      Not yet recruiting
      • Healthy
      • (no location specified)
      Nov 17, 2023

      Cystic Fibrosis (CF) Trial in Worldwide (Galicaftor, Placebo, Navocaftor)

      Active, not recruiting
      • Cystic Fibrosis (CF)
      • Mobile, Alabama
      • +46 more
      Oct 20, 2022

      DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)

      Not yet recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Louisville, Kentucky
      • +6 more
      Nov 14, 2022

      Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • Kashiwa-shi, Chiba, Japan
      • +5 more
      Jan 25, 2023